相关实验视频

Updated: May 31, 2025

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Published on: June 18, 2012

向CD84蛋白在髓质衍生抑制细胞上作为固体瘤中新型免疫疗法

Saeed Mobini¹, Milad Chizari², Elham Rismani³

¹Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Computer methods and programs in biomedicine

|January 23, 2025

概括

研究人员设计了强大的和抗体来阻断CD84相互作用,这对于固体瘤中的髓衍生抑制细胞 (MDSC) 至关重要. 这些新型疗法显示出明显更高的结合亲和力,为癌症免疫治疗提供了一个有前途的策略.

科学领域:

免疫学免疫学免疫学
计算生物学计算生物学
结构生物学结构生物学

背景情况:

骨髓系衍生抑制细胞 (MDSCs) 是瘤微环境 (TME) 的关键调节者,促进瘤的进展,入侵和转移.
CD84是MDSC上的同型粘附分子,对它们在TME中的积累和功能至关重要.
向CD84相互作用为固体瘤提供了潜在的治疗策略.

研究的目的:

通过分子动力学模拟来研究CD84的蛋白质-蛋白质相互作用.
设计和评估针对CD84相互作用的新型抗体.
探索在固体瘤中针对MDSCs的免疫治疗的潜在治疗策略.

主要方法:

使用计算技术生成突变的CD84小蛋白和作为对抗剂.
一种能够阻断CD84的抗体被设计出来.
用解离常数 (Kd) 的计算和吉布斯自由能量变化 (ΔΔG) 来评估结合亲和度.

主要成果:

设计的表现出比自然CD84相互作用的10到100倍更强的结合亲和力 (Kd),这表明有效的抑制.
CD84的Ig样V域的突变产生了具有增强结合稳定性和相互作用潜力的变体 (ΔΔG).
计算模型表明CD84介导相互作用的强烈对抗性.

结论:

这项研究提供了关于CD84相互作用及其在固体瘤中向MDSC的潜力.
工程化和抗体对CD84具有很高的亲和力,这表明其具有治疗潜力.
需要进行实验验证,以确认发现并评估分子治疗的选择性.

关键词:

癌症免疫疗法癌症免疫疗法来自骨髓细胞的抑制细胞.这是一种SLAMF5糖蛋白.

更多相关视频

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Murine Model of CD40-activation of B cells

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.